Pharmicell Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pharmicell Company Limited with three other
companies in this sector in South Korea:
Ildong Holdings Co Ltd
sales of 41.07 billion Korean Won [US$38.36 million]
of which 32%
Jeil Pharma Holdings Inc
(44.44 billion Korean Won [US$41.51 million]
of which 96%
was medicines), and
Daesung Microbiological Labs. Co., Limited
(24.04 billion Korean Won [US$22.46 million]
During the year ended December of 2017, sales at
Pharmicell Company Limited were 25.20 billion Korean Won (US$23.53 million).
decrease of 9.5%
versus 2016, when the company's sales were 27.84 billion Korean Won.
Contributing to the drop in overall sales was the 32.7% decline
in Bio-Business, from 4.74 billion Korean Won to 3.19 billion Korean Won.
There were also decreases in sales in
Chemical (down 4.7% to 22.00 billion Korean Won)